27203-24-3

Basic information

• Product Name: amidinoformic acid
• CAS NO: 27203-24-3
• Molecular Weight: 88.066
• Mol File: 27203-24-3.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: amidinoformic acid(CAS DataBase Reference)
• NIST Chemistry Reference: amidinoformic acid(27203-24-3)
• EPA Substance Registry System: amidinoformic acid(27203-24-3)

Safety Data

• Hazardous Substances Data: 27203-24-3(Hazardous Substances Data)

Upstream product

• 145250-81-3 2,2-dinitroethene-1,1-diamine 
• 34669-71-1 potassium oxathioamidate 
• 16982-21-1 Imino-mercapto-acetic acid ethyl ester 
• 143-33-9 sodium cyanide 
• 501-53-1 benzyl chloroformate 
• 505-73-7 disulfanediyldiacetic acid 

Downstream Products

• 700796-91-4 methyl 2-amino-2-iminoacetate 

Relevant articles and documents

Tetranitroacetimidic acid: A high oxygen oxidizer and potential replacement for ammonium perchlorate

Considerable work has been focused on developing replacements for ammonium perchlorate (AP), a primary choice for solid rocket and missile propellants, due to environmental concerns resulting from the release of perchlorate into groundwater systems, which has been linked to thyroid cancer. Additionally, the generation of hydrochloric acid contributes to high concentrations of acid rain and to ozone layer depletion. En route to synthesizing salts that contain cationic FOX-7, a novel, high oxygen-containing oxidizer, tetranitroacetimidic acid (TNAA), has been synthesized and fully characterized. The properties of TNAA were found to be exceptional, with a calculated specific impulse exceeding that of AP, leading to its high potential as a replacement for AP. TNAA can be synthesized easily in a one-step process by the nitration of FOX-7 in high yield (>93%). The synthesis, properties, and chemical reactivity of TNAA have been examined.

Novel compounds and methods for synthesis and therapy

Novel compounds are described. The compounds generally comprise an acidic group, a basic group, a substituted amino or N-acyl and a group having an optionally hydroxylated alkane moiety. Pharmaceutical compositions comprising the inhibitors of the invention are also described. Methods of inhibiting neuraminidase in samples suspected of containing neuraminidase are also described. Antigenic materials, polymers, antibodies, conjugates of the compounds of the invention with labels, and assay methods for detecting neuraminidase activity are also described.

Compounds and methods for synthesis and therapy

Novel compounds are described. The compounds generally comprise an acidic group, a basic group, a substituted amino or N-acyl and a group having an optionally hydroxylated alkane moiety. Pharmaceutical compositions comprising the inhibitors of the invention are also described. Methods of inhibiting neuraminidase in samples suspected of containing neuraminidase are also described. Antigenic materials, polymers, antibodies, conjugates of the compounds of the invention with labels, and assay methods for detecting neuraminidase activity are also described.